CLEO Further Expands Ovarian Cancer Trial with Siles Health

Cleo Diagnostics (COV:AU) has announced CLEO Further Expands Ovarian Cancer Trial with Siles Health

Download the PDF here.

This post appeared first on investingnews.com

Other news

26-12-2024 20:10

Digital health companies pummeled by Wall Street in 2024 as industry adapts to post-Covid slowdown

26-12-2024 16:10

Starbucks barista strike expands as workers demand pay raises

Enter Your Information Below To Receive Latest News, And Articles.

Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!